Soraia Lobo-Martins: New Review on Younger Women With ER-positive Early Breast Cancer

Soraia Lobo-Martins, Medical Advisor and Medical Research Fellow, Institut Jules Bordet, shared a post on LinkedIn:

“New publication in Nature Reviews Clinical Oncology, Springer Nature

I am very pleased to share our newly published review on Tailoring targeted therapies for younger premenopausal women with ER-positive early breast cancer.

We discuss how 𝗱𝗶𝘀𝘁𝗶𝗻𝗰𝘁 𝗴𝗲𝗻𝗼𝗺𝗶𝗰, 𝗵𝗼𝗿𝗺𝗼𝗻𝗮𝗹 𝗮𝗻𝗱 𝗶𝗺𝗺𝘂𝗻𝗲 𝗳𝗲𝗮𝘁𝘂𝗿𝗲𝘀 should guide treatment escalation and de-escalation strategies – beyond chronological age alone.

Grateful to collaborate with Stephen J. Luen, Martine Piccart and Sherene Loi.”

Title: Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer

Authors: Soraia Lobo-Martins,  Stephen J. Luen, Martine Piccart and Sherene Loi 

Read the article

More posts featuring Soraia Lobo-Martins